Montagu acquires Arkopharma

The firm has acquired the business from Max Rombi, who founded the company in 1980, and his family. In 2008, Rombi passed control of the business to his son Philippe, who is now CEO.

Montagu will support the company's domestic and international growth strategy. The firm also plans to aid the company in consolidating the phytotherapy industry, which it says is currently very fragmented.

Montagu has recently made several acquisitions within the healthcare space. Last week the firm acquired Dutch Ophthalmic Research Center from Rabo Capital in a secondary buyout, marking the firm's first lead investment in the Netherlands.

At the beginning of February, Montagu purchased the healthcare devices and prescription retail divisions of UK consumer packaging company Rexam for $805m in cash.

In June last year, the GP bought Chertsey-based Clinisys, a provider of IT systems to the healthcare sector, from ECI Partners. The sale rewarded ECI with a 2.5x money multiple on its investment.

Company
Founded in 1980, Arkopharma is headquartered in Carros with additional offices in Italy and Ireland. The company employs 1,413 staff and generates annual revenues of around €200m.

Arkopharma is a pharmaceutical company specialising in natural medicine, dietary supplements and phytotherapy – the use of natural extracts as medicine. The company has several brands, such as Arkogélules, Forcapil and Cys-Control, and develops products for digestion, joints, skin, women's health, hair and nails, slimming and colds.

People
Philippe Rombi is the CEO of Arkopharma. Sylvain Berger-Duquene is a director and head of Montagu's French and German offices.

Advisers
Equity – Lazard (Corporate finance).
Vendors – Transaction R (Corporate finance).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• France
• Healthcare
• Buyouts
• France
• Montagu Private Equity